Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
340 Leser
Artikel bewerten:
(2)

Sky Labs: 'CART BP pro' Opens a New Paradigm in Blood Pressure Management, Maintaining Accuracy Across Arm Positions

SEOUL, South Korea, Sept. 5, 2025 /PRNewswire/ -- At the European Society of Cardiology (ESC) Congress 2025, held in Madrid from August 29 to September 1, Sky Labs presented new clinical findings on CART BP pro, its cuffless, ring-type blood pressure monitor. The device demonstrated consistent accuracy even when the arm was positioned below heart level, meeting the rigorous validation requirements set by the European Society of Hypertension (ESH).

ESC 2025 Session - Professor Jihoon Kim of Samsung Medical Center presents findings on the accuracy of CART BP pro across arm positions, highlighting its clinical use in Korea.

The ESH recommends six validation tests for cuffless blood pressure devices, namely the static test for absolute accuracy, the device position test for robustness against hydrostatic pressure, the treatment test for accuracy in detecting blood pressure decreases, the awake-asleep test for changes across circadian patterns, the exercise test for increases during physical activity, and the recalibration test for long-term cuff calibration stability.

Accuracy Across Positions

On August 29, Professor Jihoon Kim of Samsung Medical Center presented "Assessing the accuracy of a ring-type cuffless blood pressure device across postures". The session was chaired by Professor Seok Min Kang, President of the Korean Society of Cardiology, and Professor Eugene Yang, Chair of the American College of Cardiology (ACC) Prevention of Cardiovascular Disease Section.

Professor Kim reported that CART BP pro passed the ESH accuracy criteria across different arm positions. He stated, "Traditional cuff-based devices require the arm to be positioned at heart level. CART BP pro maintained accuracy regardless of arm position, representing a significant step forward for 24/7 cuffless blood pressure monitoring."

Study results confirmed no significant differences between heart-level and lower-position readings, with outcomes consistent with standard auscultatory measurements. Professor Kim added that the device is less affected by hydrostatic pressure, ensuring reliable results across various postures.

Smarter 24-Hour Monitoring

On August 30, Professor Hae-Young Lee of Seoul National University Hospital presented "24-Hour Accuracy of a Ring-Type Cuffless Blood Pressure Monitor Based on the ESH 2023 Recommendations." The session was co-chaired by Professor George Stergiou, President of the International Society of Hypertension, and Professor Gregory Lip of the University of Liverpool.

Professor Lee presented study results demonstrating that CART BP pro accurately captured blood pressure variations between awake and asleep periods, in line with the ESH 2023 recommendations. He further emphasized the importance of 24-hour blood pressure monitoring for identifying patient risk profiles. He noted that, while ambulatory blood pressure monitoring remains the clinical gold standard, it is limited by patient discomfort and infrequent readings. By contrast, CART BP pro enabled more frequent and comfortable measurements across the full 24-hour cycle.

Nocturnal BP and Sleep Apnea

In the final session, Professor Woo-Seok Ha of Severance Hospital presented "Nocturnal Blood Pressure and OSA: Insights from Simultaneous PSG and Ring-Type Monitoring." The session was chaired by Professor Gianfranco Parati of the University of Milano-Bicocca, President of the World Hypertension League, and Professor Alta Schutte of the University of New South Wales.

Professor Ha explained that nocturnal blood pressure variability differs depending on the type and duration of obstructive sleep apnea events. He noted that the study findings suggest CART BP pro may enable nocturnal blood pressure monitoring without disturbing sleep, potentially serving as a useful tool to stratify OSA risk and to assess long-term cardiovascular outcomes.

Expanding Access

Since its launch in September 2024, CART BP pro has been adopted by more than 1,600 hospitals and clinics nationwide. Sky Labs also announced plans to release a next-generation consumer model in late September 2025, available over the counter and supported by a dedicated mobile application, further expanding access to convenient and reliable blood pressure monitoring.

About Sky Labs https://www.skylabs.io/

Founded in September 2015, Sky Labs is a leading healthcare startup that has developed CART (Cardio Tracker), a ring-shaped medical device designed for disease monitoring using heart signals collected through optical sensors. Following this, the company developed CART BP, a cuffless, ring-shaped device that enables continuous 24-hour blood pressure monitoring, providing valuable treatment information and making a groundbreaking contribution to improving the quality of life for hypertension patients. Sky Labs has signed an exclusive domestic distribution agreement for CART BP with South Korea's Daewoong Pharmaceutical and is preparing for nationwide sales to hospitals, clinics, and general consumers.

Media Inquiries
Inok Jung - inok.jung@skylabs.io
Junehee Yu - junehee.yu@skylabs.io

Sky Labs

Photo - https://mma.prnewswire.com/media/2765674/Professor_Jihoon_Kim_Samsung_Medical_Center.jpg
Logo - https://mma.prnewswire.com/media/2765675/Sky_Labs_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/cart-bp-pro-opens-a-new-paradigm-in-blood-pressure-management-maintaining-accuracy-across-arm-positions-302547704.html

© 2025 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.